Free Trial

Dermata Therapeutics (DRMA) Stock Trends and Sentiment

-0.11 (-3.25%)
(As of 05/28/2024 ET)

Media Mentions Over Time

View Trending Media Stocks

MarketBeat Searches Over Time

Recieve Dermata Therapeutics News and Ratings via Email

Sign-up to receive the latest news and ratings for DRMA and its competitors with MarketBeat's FREE daily newsletter.

Related Companies and Tools

This page (NASDAQ:DRMA) was last updated on 5/28/2024 by Staff

From Our Partners